The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation

A Langdon, N Crook, G Dantas - Genome medicine, 2016 - Springer
The widespread use of antibiotics in the past 80 years has saved millions of human lives,
facilitated technological progress and killed incalculable numbers of microbes, both …

Anti-virulence strategies to combat bacteria-mediated disease

DA Rasko, V Sperandio - Nature reviews Drug discovery, 2010 - nature.com
Antibiotic resistance is one of the greatest challenges of the twenty-first century. However,
the increasing understanding of bacterial pathogenesis and intercellular communication has …

On the use of surface plasmon resonance biosensing to understand IgG-FcγR interactions

C Forest-Nault, J Gaudreault, O Henry… - International Journal of …, 2021 - mdpi.com
Surface plasmon resonance (SPR)-based optical biosensors offer real-time and label-free
analysis of protein interactions, which has extensively contributed to the discovery and …

Monoclonal antibody therapies against anthrax

Z Chen, M Moayeri, R Purcell - Toxins, 2011 - mdpi.com
Anthrax is a highly lethal infectious disease caused by the spore-forming bacterium Bacillus
anthracis. It not only causes natural infection in humans but also poses a great threat as an …

Anti-bacterial monoclonal antibodies: back to the future?

MB Oleksiewicz, G Nagy, E Nagy - Archives of biochemistry and biophysics, 2012 - Elsevier
Today's medicine has to deal with the emergence of multi-drug resistant bacteria, and is
beginning to be confronted with pan-resistant microbes. This worsening inadequacy of the …

Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles

S Tang, M Moayeri, Z Chen, H Harma… - Clinical and vaccine …, 2009 - Am Soc Microbiol
We developed a europium nanoparticle-based immunoassay (ENIA) for the sensitive
detection of anthrax protective antigen (PA). The ENIA exhibited a linear dose-dependent …

[HTML][HTML] Potent Monoclonal antibodies neutralize Omicron Sublineages and other SARS-Cov-2 variants

Z Chen, P Zhang, Y Matsuoka, Y Tsybovsky, K West… - Cell Reports, 2022 - cell.com
The emergence and global spread of the SARS-CoV-2 Omicron variants, which carry an
unprecedented number of mutations, raise serious concerns due to the reduced efficacy of …

Probing the functional heterogeneity of surface binding sites by analysis of experimental binding traces and the effect of mass transport limitation

J Svitel, H Boukari, D Van Ryk, RC Willson, P Schuck - Biophysical journal, 2007 - cell.com
Many techniques rely on the binding activity of surface-immobilized proteins, including
antibody-based affinity biosensors for the detection of analytes, immunoassays, protein …

Monoclonal antibodies and toxins—a perspective on function and isotype

SK Chow, A Casadevall - Toxins, 2012 - mdpi.com
Antibody therapy remains the only effective treatment for toxin-mediated diseases. The
development of hybridoma technology has allowed the isolation of monoclonal antibodies …

Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis

Z Chen, SV Sosnovtsev, K Bok, GI Parra… - Journal of …, 2013 - Am Soc Microbiol
Passive immunoprophylaxis or immunotherapy with norovirus-neutralizing monoclonal
antibodies (MAbs) could be a useful treatment for high-risk populations, including infants …